We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
+7.19%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$836M
AUM Growth
+$219M
Cap. Flow
+$188M
Cap. Flow %
22.5%
Top 10 Hldgs %
4.49%
Holding
1,220
New
441
Increased
247
Reduced
213
Closed
319

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$4.41M
2
AAP icon
Advance Auto Parts
AAP
+$4.15M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.96M
4
DLTR icon
Dollar Tree
DLTR
+$3.82M
5
MSFT icon
Microsoft
MSFT
+$3.74M

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$2.82M
2
KO icon
Coca-Cola
KO
+$2.82M
3
GD icon
General Dynamics
GD
+$2.82M
4
ORCL icon
Oracle
ORCL
+$2.81M
5
HLNE icon
Hamilton Lane
HLNE
+$2.8M

Sector Composition

Rank Sector Weight
1 Technology 16.51%
2 Industrials 15.72%
3 Consumer Discretionary 15.68%
4 Healthcare 13.43%
5 Financials 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UWMC icon
1176
UWM Holdings
UWMC
$624M
– –
-16,849
Closed -$117K
VAC icon
1177
Marriott Vacations Worldwide
VAC
$3.4B
– –
-4,774
Closed -$417K
VECO icon
1178
Veeco
VECO
$2.96B
– –
-6,503
Closed -$304K
VFC icon
1179
VF Corp
VFC
$6.72B
– –
-28,715
Closed -$388K
VICR icon
1180
Vicor
VICR
$9.41B
– –
-7,186
Closed -$238K
VNOM icon
1181
Viper Energy
VNOM
$8.4B
– –
-19,104
Closed -$717K
VRDN icon
1182
Viridian Therapeutics
VRDN
$2.18B
– –
-18,897
Closed -$246K
VRTX icon
1183
Vertex Pharmaceuticals
VRTX
$122B
– –
-2,775
Closed -$1.3M
VSH icon
1184
Vishay Intertechnology
VSH
$5.7B
– –
-33,265
Closed -$742K
VST icon
1185
Vistra
VST
$53B
– –
-8,897
Closed -$765K
VVX icon
1186
V2X
VVX
$2.73B
– –
-5,858
Closed -$281K
VYX icon
1187
NCR Voyix
VYX
$1.13B
– –
-18,978
Closed -$234K
WAB icon
1188
Wabtec
WAB
$50.8B
– –
-12,752
Closed -$2.02M
WDFC icon
1189
WD-40
WDFC
$3.13B
– –
-2,365
Closed -$519K
WEC icon
1190
WEC Energy
WEC
$37.1B
– –
-5,814
Closed -$456K
WELL icon
1191
Welltower
WELL
$175B
– –
-10,033
Closed -$1.05M
WFC icon
1192
Wells Fargo
WFC
$264B
– –
-32,818
Closed -$1.95M
WKC icon
1193
World Kinect Corp
WKC
$2.04B
– –
-10,098
Closed -$261K
WMG icon
1194
Warner Music
WMG
$14.4B
– –
-15,465
Closed -$474K
WSM icon
1195
Williams-Sonoma
WSM
$27.6B
– –
-2,868
Closed -$405K
WST icon
1196
West Pharmaceutical
WST
$23.3B
– –
-2,445
Closed -$805K
WTI icon
1197
W&T Offshore
WTI
$492M
– –
-45,023
Closed -$96.3K
WTS icon
1198
Watts Water Technologies
WTS
$11.5B
– –
-14,673
Closed -$2.69M
WU icon
1199
Western Union
WU
$2.55B
– –
-11,570
Closed -$141K
WWD icon
1200
Woodward
WWD
$25B
– –
-3,296
Closed -$575K
45 46 47
48
49

Similar funds

SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return

Nebula Research & Development's Q3 2024 Portfolio in Review

As of Q3 2024, Nebula Research & Development held 1,220 positions worth $836M, up 35% from $618M the previous quarter. Its ten largest holdings account for 4.5% of the portfolio.

Nebula Research & Development deployed $188M of net new capital in Q3 2024, opening 441 new positions and adding to 247 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Travelers Companies, an estimated $2.39M trimmed.

  • Nebula Research & Development's largest Q3 2024 buy was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.
  • Nebula Research & Development added most to Dollar Tree in Q3 2024, an estimated $3.82M increase.
  • Nebula Research & Development's biggest Q3 2024 reduction was Travelers Companies, cutting an estimated $2.39M.
  • Nebula Research & Development fully exited Bank of America in Q3 2024, selling an estimated $2.82M.
  • Nebula Research & Development's ten largest holdings make up 4.5% of its $836M portfolio in Q3 2024.
  • Nebula Research & Development opened 441 new positions and closed 319 in Q3 2024.
  • Nebula Research & Development's portfolio value rose 35% quarter-over-quarter to $836M.

Based on Nebula Research & Development's 13F filing for Q3 2024, filed 14 Nov 2024.